EXPECT Trademark

Trademark Overview

On Thursday, October 23, 2008, a trademark application was filed for EXPECT with the United States Patent and Trademark Office. The USPTO has given the EXPECT trademark a serial number of 77598702. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 22, 2016. This trademark is owned by Celgene Corporation. The EXPECT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials in the field of hematology and oncology
expect

General Information

Serial Number77598702
Word MarkEXPECT
Filing DateThursday, October 23, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 22, 2016
Registration Number3724457
Registration DateTuesday, December 15, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 5, 2009

Trademark Statements

Goods and ServicesMedical and scientific research, namely, conducting clinical trials in the field of hematology and oncology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 22, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, July 22, 2016CANCELLED SEC. 8 (6-YR)
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 15, 2009REGISTERED-PRINCIPAL REGISTER
Thursday, November 5, 20091(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, November 2, 2009NOTICE OF ALLOWANCE CANCELLED
Thursday, November 5, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 2, 2009TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, July 28, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 29, 2009TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, May 5, 2009PUBLISHED FOR OPPOSITION
Wednesday, April 15, 2009NOTICE OF PUBLICATION
Monday, March 30, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 26, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 25, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 25, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 25, 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, February 4, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, February 4, 2009LETTER OF SUSPENSION E-MAILED
Wednesday, February 4, 2009SUSPENSION LETTER WRITTEN
Saturday, January 31, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 31, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 31, 2009ASSIGNED TO LIE
Thursday, January 29, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 28, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 28, 2009NON-FINAL ACTION E-MAILED
Wednesday, January 28, 2009NON-FINAL ACTION WRITTEN
Tuesday, January 27, 2009ASSIGNED TO EXAMINER
Monday, October 27, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

expect trials field hematology oncology clinical conducting scientific research namely medical